Comparative Analysis of Regulatory Approval Processes for Medical Devices in India and the European Union
Abstract
The regulatory approval framework for medical devices is essential to ensure safety, performance, and quality before market entry. This article presents a comparative analysis of the approval processes in India and the European Union (EU), highlighting structural and procedural differences. In India, devices are regulated under the Medical Devices Rules, 2017 by the Central Drugs Standard Control Organization (CDSCO), using a risk-based classification system with defined requirements for licensing, clinical investigation, and post-market surveillance. In contrast, the EU Medical Device Regulation (EU) 2017/745 (MDR) establishes a more comprehensive framework involving notified bodies, conformity assessment, CE marking, clinical evaluation, and stringent vigilance mechanisms. This comparison supports strategic regulatory planning and identifies opportunities for harmonization in global medical device regulation.
Conclusion: This comparative analysis of the regulatory approval processes for medical devices in India and the European Union demonstrates that both jurisdictions are grounded in risk-based regulatory philosophy, yet differ substantially in the depth, structure, and lifecycle integration of regulatory oversight.
Downloads
References
2. Government of India. Medical Devices Rules, 2017 [Internet]. New Delhi: Ministry of Health and Family Welfare; 2017 [cited 2026 Mar 6]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadGazetteFiles/Medical%20Devices%20Rules%202017.pdf
3. European Parliament and Council. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices [Internet]. Brussels: European Union; 2017 [cited 2026 Mar 6]. Available from: https://eur-lex.europa.eu/eli/reg/2017/745/oj
4. World Health Organization. Global model regulatory framework for medical devices including in vitro diagnostic medical devices [Internet]. Geneva: World Health Organization; 2017 [cited 2026 Mar 6]. Available from: https://apps.who.int/iris/handle/10665/255177
5. Shuren J, Califf RM. Need for a national evaluation system for health technology. N Engl J Med. 2016; 375(12):1093–1095.
6. India Brand Equity Foundation. Medical devices industry in India [Internet]. New Delhi: IBEF; 2024 [cited 2026 Mar 6]. Available from: https://www.ibef.org/industry/medical-devices
7. International Organization for Standardization. ISO 13485:2016 Medical devices — Quality management systems — Requirements for regulatory purposes [Internet]. Geneva: ISO; 2016 [cited 2026 Mar 6]. Available from: https://www.iso.org/standard/59752.html
8. Lahiri S, Bansal A, Kumar A. Regulatory landscape of medical devices in India: evolution and challenges. J Clin Res Regul Affairs. 2021; 38(4):210–218. Available from: https://doi.org/10.1080/10601333.2021.1892567
9. MedTech Europe. The European medical technology industry in figures 2024 [Internet]. Brussels: MedTech Europe; 2024 [cited 2026 Mar 6]. Available from: https://www.medtecheurope.org/resource-library/the-european-medical-technology-industry-in-figures
10. International Medical Device Regulators Forum. Principles of medical device classification [Internet]. IMDRF; 2019 [cited 2026 Mar 6]. Available from: https://www.imdrf.org/documents/principles-medical-device-classification
11. Central Drugs Standard Control Organization. Guidance document on common submission format for registration of medical devices in India [Internet]. New Delhi: CDSCO; 2018 [cited 2026 Mar 6]. Available from: https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadGuidelinesFiles/Medical%20Device%20Registration.pdf
12. National Accreditation Board for Certification Bodies. Accreditation requirements for medical device conformity assessment bodies [Internet]. New Delhi: Quality Council of India; 2020 [cited 2026 Mar 6]. Available from: https://nabcb.qci.org.in
13. Indian Pharmacopoeia Commission. Materiovigilance Programme of India (MvPI): guidance document [Internet]. Ghaziabad: IPC; 2022 [cited 2026 Mar 6]. Available from: https://www.ipc.gov.in/materiovigilance-programme-of-india.html
14. European Commission. Medical Device Coordination Group (MDCG) guidance documents under Regulation (EU) 2017/745 [Internet]. Brussels: European Commission; 2024 [cited 2026 Mar 6]. Available from: https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents_en
15. Ernst & Young. Impact of the EU Medical Device Regulation on innovation and market access [Internet]. London: EY; 2020 [cited 2026 Mar 6]. Available from: https://www.ey.com/en_gl/life-sciences/eu-medical-device-regulation
16. European Commission. EUDAMED and Unique Device Identification (UDI) system guidance [Internet]. Brussels: European Commission; 2022 [cited 2026 Mar 6]. Available from: https://health.ec.europa.eu/medical-devices-sector/new-regulations/eudamed_en
17. Bianchini E, et al. Clinical evidence requirements under the EU MDR: implications for manufacturers. Expert Rev Med Devices. 2021; 18(6):501–510. Available from: https://doi.org/10.1080/17434440.2021.1922420
18. Rausand M. Post-market surveillance and vigilance under the EU MDR framework. Regul Toxicol Pharmacol. 2022; 131:105151. Available from: https://doi.org/10.1016/j.yrtph.2022.105151
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
